Literature DB >> 29479241

Audit of pulse oximetry screening for critical congenital heart disease (CCHD) in newborns.

Marnie Lightfoot1, Philip Hough1, Alan Hudak1, Michelle Gordon1, Sarah Barker1, Robert Meeder1, Melanie Colpitts1, Gwendolyn Roberts1, William Gary Smith1.   

Abstract

OBJECTIVES: To assess the efficacy of a new screening protocol for critical congenital heart disease (CCHD).
BACKGROUND: In March 2014, the Ontario Provincial Council for Maternal Child Health (PCMCH) recommended screening for CCHD, utilizing pulse oximetry to measure oxygen saturation as part of the newborn examination. However, this is yet to be implemented in all hospitals.
METHOD: An audit of consecutive healthy normal newborn patients in a secondary level centre in Ontario with early adoption of the screening recommendation over a 1-year period was undertaken.
RESULTS: The median age of screening was 25 hours (6 to 80 hours). Compliance was 88% (95% if one excludes deliveries by a midwife as they did not agree to comply). Four patients screened positive and were seen by a paediatrician in consultation but did not have CCHD (specificity 99.4%).
CONCLUSIONS: The current study shows that screening was successfully implemented in a Canadian hospital, with high specificity (99.4%) and good compliance (88%). Reasons for non-acceptance of screening by midwives need to be addressed.

Entities:  

Keywords:  Critical congenital heart disease; Screening

Year:  2017        PMID: 29479241      PMCID: PMC5804783          DOI: 10.1093/pch/pxx091

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  6 in total

1.  Implementing recommended screening for critical congenital heart disease.

Authors:  Gerard R Martin; Robert H Beekman; Elizabeth Bradshaw Mikula; James Fasules; Lorraine F Garg; Alex R Kemper; W Robert Morrow; Gail D Pearson; William T Mahle
Journal:  Pediatrics       Date:  2013-06-17       Impact factor: 7.124

2.  Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study.

Authors:  Qu-ming Zhao; Xiao-jing Ma; Xiao-ling Ge; Fang Liu; Wei-li Yan; Lin Wu; Ming Ye; Xue-cun Liang; Jing Zhang; Yan Gao; Bing Jia; Guo-ying Huang
Journal:  Lancet       Date:  2014-04-22       Impact factor: 79.321

3.  Strategies for implementing screening for critical congenital heart disease.

Authors:  Alex R Kemper; William T Mahle; Gerard R Martin; W Carl Cooley; Praveen Kumar; W Robert Morrow; Kellie Kelm; Gail D Pearson; Jill Glidewell; Scott D Grosse; R Rodney Howell
Journal:  Pediatrics       Date:  2011-10-10       Impact factor: 7.124

4.  Cost-effectiveness of routine screening for critical congenital heart disease in US newborns.

Authors:  Cora Peterson; Scott D Grosse; Matthew E Oster; Richard S Olney; Cynthia H Cassell
Journal:  Pediatrics       Date:  2013-08-05       Impact factor: 7.124

5.  Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP.

Authors:  William T Mahle; Jane W Newburger; G Paul Matherne; Frank C Smith; Tracey R Hoke; Robert Koppel; Samuel S Gidding; Robert H Beekman; Scott D Grosse
Journal:  Pediatrics       Date:  2009-07-06       Impact factor: 7.124

6.  Prenatal and newborn screening for critical congenital heart disease: findings from a nursery.

Authors:  Lise C Johnson; Ellice Lieberman; Edward O'Leary; Robert L Geggel
Journal:  Pediatrics       Date:  2014-10-06       Impact factor: 7.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.